166 related articles for article (PubMed ID: 8387758)
1. [Transcatheter chemoembolization of hepatocellular carcinoma (TAE)--its application and limitations].
Hashimoto T; Hori S; Nakamura H
Gan To Kagaku Ryoho; 1993 May; 20(7):877-83. PubMed ID: 8387758
[TBL] [Abstract][Full Text] [Related]
2. [Sequential hepatic artery and portal vein embolization using lipiodol-adriamycin for primary liver cancer].
Pan CE
Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):372-4. PubMed ID: 1664318
[TBL] [Abstract][Full Text] [Related]
3. [Transcatheter chemoembolization combined with hepatectomy for primary hepatic carcinoma. A clinical and pathological study].
Liu YX
Zhonghua Wai Ke Za Zhi; 1992 Jun; 30(6):342-5, 382. PubMed ID: 1337514
[TBL] [Abstract][Full Text] [Related]
4. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations].
Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T
Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994
[TBL] [Abstract][Full Text] [Related]
5. [Residual liver cancer after transcatheter hepatic arterial chemoembolization in patients with large primary hepatic carcinoma].
Tan YS
Zhonghua Wai Ke Za Zhi; 1992 Jun; 30(6):346-8, 382. PubMed ID: 1337515
[TBL] [Abstract][Full Text] [Related]
6. [Limitation of oily chemoembolization against hepatocellular carcinoma and arterioportal segmental chemoembolization].
Nakamura H; Hashimoto T; Fujita M; Oi H; Inoue K; Mizumoto S; Sawada S; Takayasu Y; Hori S; Furui S
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2849-52. PubMed ID: 2551227
[TBL] [Abstract][Full Text] [Related]
7. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
Jin-no K
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
[TBL] [Abstract][Full Text] [Related]
8. [Segmental simultaneous arterio-portal chemoembolization of hepatocellular carcinoma].
Oi H
Nihon Rinsho; 1991 Aug; 49(8):1910-5. PubMed ID: 1664898
[No Abstract] [Full Text] [Related]
9. Transcatheter oily chemoembolization for the treatment of large hepatocellular carcinoma with an accompanying tumor thrombus in the right main branch of the portal vein and arterioportal shunting: report of one patient still surviving after more than seven years.
Inoue K; Akaji H; Nakamura H
Radiat Med; 1991; 9(3):105-7. PubMed ID: 1656485
[TBL] [Abstract][Full Text] [Related]
10. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter oily chemoembolization with high doses of adriamycin in the treatment of large hepatocellular carcinoma (10 cm or more in diameter).
Nakamura H; Hashimoto T; Inoue Y; Inoue K; Akaji H; Sawada S
Radiat Med; 1990; 8(5):188-90. PubMed ID: 1963695
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
[TBL] [Abstract][Full Text] [Related]
13. [Oily chemoembolization of hepatoma].
Nakamura H; Hashimoto T; Taguchi T; Oi H; Inoue K; Seki K; Mizumoto S; Tsukaguchi I; Araki Y; Sawada S
Gan To Kagaku Ryoho; 1987 Feb; 14(2):381-7. PubMed ID: 3028276
[TBL] [Abstract][Full Text] [Related]
14. [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma].
Shimamura Y; Ishii M; Shima Y; Takenaka H; Taniguchi H; Watanabe H; Kitai S; Sugai S; Takahashi A; Kitaya T
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
[TBL] [Abstract][Full Text] [Related]
16. [Chemoembolization therapy in small hepatocellular carcinoma].
Uchida H; Matsuo N; Sakaguchi H; Nishimine K; Anai H; Ohishi H
Gan To Kagaku Ryoho; 1996 Jun; 23(7):840-8. PubMed ID: 8678531
[TBL] [Abstract][Full Text] [Related]
17. [Anticancer and side effect of arterial subsegmental chemoembolization using cisplatinum/pirarubicin lipiodol suspension (CTLS) for hepatocellular carcinoma].
Inoue H; Miyazono N; Kanetsuki I; Hori A; Tanaka D; Fukukura Y; Matsumoto Y; Nishida H; Ueno K; Nakajo M
Gan To Kagaku Ryoho; 1993 Oct; 20(13):1973-6. PubMed ID: 7692822
[TBL] [Abstract][Full Text] [Related]
18. [Chemoembolization].
Nakamura H; Hashimoto T; Taguchi T; Oi H; Nakagawa K; Inoue K; Seki K; Mizumoto S; Akashi H; Tsukaguchi I
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1656-63. PubMed ID: 3036013
[TBL] [Abstract][Full Text] [Related]
19. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter hepatic arterial therapy for symptomatic liver malignancy.
Guthrie CM; Leahy AL; Redhead DN; Garden OJ
J R Coll Surg Edinb; 1991 Dec; 36(6):384-7. PubMed ID: 1723100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
